COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,703 Articles (22,913 medRxiv, 8,790 bioRxiv)

Most recent first Previous |  Page 634: Articles 6331-6340  | Next

Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations
Tiezzi, C., Vecchi, A., Rossi, M., Cavazzini, D., Bolchi, A., Laccabue, D., Sacchelli, L., Brillo, F., Meschi, T., Ticinesi, A., Nouvenne, A., Donofrio, G., Zanelli, P., Benecchi, M., Giuliodori, S., Fisicaro, P., Montali, I., Urbani, S., Pedrazzi, G., Missale, G., Telenti, A., Corti, D., Ottonello, S., Ferrari, C., Boni, C.
10.1101/2022.10.28.513849 — Posted: 2022-10-28
Tocilizumab treatment leads to early resolution of myeloid dysfunction and lymphopenia in patients hospitalized with COVID-19
Shivram, H., Hackney, J. A., Rosenberger, C. M., Teterina, A., Qamra, A., Onabajo, O., McBride, J., Cai, F., Bao, M., Tsai, L., Regev, A., Rosas, I., Bauer, R.
10.1101/2022.10.27.514096 — Posted: 2022-10-28
A single-nucleus and spatial transcriptomic atlas of the COVID-19 liver reveals topological, functional, and regenerative organ disruption in patients
Pita-Juarez, Y., Karagkouni, D., Kalavros, N., Melms, J. C., Niezen, S., Delorey, T. M., Essene, A. L., Brook, O. R., Pant, D., Skelton-Badlani, D., Naderi, P., Huang, P., Pan, L., Hether, T., Andrews, T. S., Ziegler, C. G. K., Reeves, J., Myloserdnyy, A., Chen, R., Nam, A., Phelan, S., Liang, Y., Amin, A. D., Biermann, J., Hibshoosh, H., Veregge, M., Kramer, Z., Jacobs, C., Yalcin, Y., Phillips, D., Slyper, M., Subramanian, A., Ashenberg, O., Bloom-Ackermann, Z., Tran, V. M., Gomez, J., Sturm, A., Zhang, S., Fleming, S. J., Warren, S., Beechem, J., Hung, D., Babadi, M., Padera, R. F., MacParland, S. A., Bader, G. D., Imad, N., Solomon, I. H., Miller, E., Riedel, S., Porter, C. B. M., Villani, A.-C., Tsai, L. T.- Y., Hide, W., Szabo, G., Hecht, J., Rozenblatt-Rosen, O., Shalek, A. K., Izar, B., Regev, A., Popov, Y., Jiang, Z. G., Vlachos, I. S.
10.1101/2022.10.27.514070 — Posted: 2022-10-28
Viral load of SARS-CoV-2 Omicron BA.5 is lower than that of BA.2 despite the higher infectivity of BA.5
Takatsuki, Y., Takahashi, Y., Nakajima, J., Iwasaki, Y., Nagano, K., Tani-Sassa, C., Yuasa, S., Kanehira, S., Sonobe, K., Nukui, Y., Takeuchi, H., Tanimoto, K., Tanaka, Y., Kimura, A., Ichimura, N., Tohda, S.
10.1101/2022.10.25.22281427 — Posted: 2022-10-28
Graph-based Fusion Modeling and Explanation for Disease Trajectory Prediction
Tariq, A., Tang, S., Sakhi, H., Celi, L. A. G., Newsome, J., Rubin, D., Trivedi, H., Gicchoya, J. W., Patel, B., Banerjee, I.
10.1101/2022.10.25.22281469 — Posted: 2022-10-28
Vitamin D deficiency and SARS-CoV-2 infection: Big-data analysis from March 2020 to March 2021. D-COVID study
Anguita, N.
10.1101/2022.10.27.514012 — Posted: 2022-10-28
Intranasal virus-particle mimicking vaccine enhances SARS-CoV-2 clearance in the Syrian hamster model
Patel, D. R., Minns, A. M., Sims, D. G., Field, C. J., Kerr, A. E., Heinly, T., Luley, E. H., Rossi, R. M., Bator, C., Mostafa, I. M., Hafenstein, S. L., Lindner, S. E., Sutton, T. C.
10.1101/2022.10.27.514054 — Posted: 2022-10-27
On the frontlines in Shanghai: Stress, burnout and perceived benefit among COVID-19 testers and other personnel during the Omicron wave lockdown
Xu, Z., Liu, X., Ghisi, G. L. M., Cui, L., Grace, S. L.
10.1101/2022.10.25.22281504 — Posted: 2022-10-27
A multistage mixed-methods evaluation of the UKHSA testing response during the COVID-19 pandemic in England
Naidoo, R., Andersen-waine, B., Dahal, P., Dickinson, S., Lambert, B., Mills, M., Molyneux, C., Rowe, E., Pinto-Duschinsky, S., Stepniewska, K., Shretta, R., Voysey, M., Wanat, M., Yenidogan, G., White, L. J., EY-Oxford Health Analytics Consortium
10.1101/2022.10.27.22281604 — Posted: 2022-10-27
Complex changes in serum protein levels upon recovery from SARS-CoV2 infection
Pushalkar, S., Wu, S., Maity, S., Pressler, M., Rendleman, J., Vitrinel, B., Carlock, M. A., Ross, T., Choi, H., Vogel, C.
10.1101/2022.10.26.513886 — Posted: 2022-10-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).